Address correspondence to Avni P. Finn, MD, MBA, Vanderbilt Eye Institute, 2311 Pierce Avenue, Nashville, TN 37232; email: avni.finn@vumc.org . From the Department of Ophthalmology, Vanderbilt University Medical Center, Nashville, Tennessee. Disclosure: APF is a consultant for Genentech; and participates on advisory boards for Allergan, Apellis, Eyepoint, Genentech, and Iveric Bio. The remaining authors have disclosed no potential conflicts of interest, financial or otherwise.